Current Research Studies

Treating Parents with ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial

TPAC

What is the goal of the study?

This study proposes a Type 1 Hybrid Effectiveness-Implementation trial14 with N=240 families. The primary focus is testing the comparative effectiveness of a combined parental stimulant medication and child treatment strategy (PSM+CTS) versus CTS alone. That is, (1) PSM first followed by a child treatment strategy (CTS) consisting of BPT followed by stimulant medication if the child remains impaired vs. (2) CTS only (without PSM). Secondarily, we will assess the care context and develop an implementation approach for early intervention in multiplex ADHD families. Primary Aim 1: Compare a combined parental stimulant medication and child treatment strategy (PSM+CTS) versus CTS alone on child ADHD-related impairment (primary outcome), child ADHD and externalizing symptoms, time to child stimulant prescription (secondary child outcomes) and parental impairment, parental symptoms, parenting, and BPT engagement (parental outcomes/target mechanisms). Aim 2: Develop a more personalized intervention by testing moderators of the effect of PSM+CTS vs. CTS. Aim 3: Examine target mechanisms in leading to long-term improved child impairment due to CTS+PSM. Exploratory Aim: Assess the care delivery context and develop an implementation approach for treatment of multiplex ADHD families via telehealth in primary care sites providing pediatric care.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: